Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-24 @ 2:54 PM
NCT ID:
NCT00823459
Brief Title:
Everolimus in Treating Patients With Recurrent Low-Grade Glioma
Official Title:
Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Study:
NCT00823459
Protocol Section:
NCT00823459